News on End-Stage_Renal from BioPortfolio.com http://www.BioPortfolio.com Consolidated End-Stage_Renal news from BioPortfolio.com Wed, 10 Feb 2010 07:28:03 GMT en Preemptive Versus Sequential Prophylactic-Preemptive Treatment Regimens for Cytomegalovirus in Renal Transplantation: Comparison of Treatment Failure and Antiviral Resistancehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039290&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039290&THISHREF=http://c.moreover.com/click/here.pl%3fz2537999678%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039290&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039290&THISHREF=http://c.moreover.com/click/here.pl%3fz2537999678%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTransplantation: Pharmasset Reports Fiscal First Quarter 2010 Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039626&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039626&THISHREF=http://c.moreover.com/click/here.pl%3fz2538265258%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039626&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039626&THISHREF=http://c.moreover.com/click/here.pl%3fz2538265258%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Amgen Tourhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039931&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039931&THISHREF=http://c.moreover.com/click/here.pl%3fz2538481979%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039931&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039931&THISHREF=http://c.moreover.com/click/here.pl%3fz2538481979%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKCRA.com: Cancer survivor rides to benefit researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039863&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039863&THISHREF=http://c.moreover.com/click/here.pl%3fz2538440079%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039863&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039863&THISHREF=http://c.moreover.com/click/here.pl%3fz2538440079%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTampa Tribune: Austria's Anagnostics to Launch Cylindrical Array Platform by Year Endhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039146&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039146&THISHREF=http://c.moreover.com/click/here.pl%3fz2537958293%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039146&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039146&THISHREF=http://c.moreover.com/click/here.pl%3fz2537958293%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenomeWeb: YM BioSciences Merges with Cytopia Ltd.; Reports Second Quarter Loss of $3.4Mhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039881&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039881&THISHREF=http://c.moreover.com/click/here.pl%3fz2538447334%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039881&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039881&THISHREF=http://c.moreover.com/click/here.pl%3fz2538447334%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceuticalProcessing: 3SBio Gains China Rights to Another Dialysis Drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033820&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033820&THISHREF=http://c.moreover.com/click/here.pl%3fz2535413965%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033820&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033820&THISHREF=http://c.moreover.com/click/here.pl%3fz2535413965%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSeeking Alpha: Dialysis center plans progress at hospital herehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035899&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035899&THISHREF=http://c.moreover.com/click/here.pl%3fz2536415512%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035899&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035899&THISHREF=http://c.moreover.com/click/here.pl%3fz2536415512%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarysville Advocate: Raloxifene decreases serum malondialdehyde and nitric oxide levels in postmenopausal women with end-stage renal disease under chronic hemodialysis therapyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034322&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034322&THISHREF=http://c.moreover.com/click/here.pl%3fz2535717020%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034322&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034322&THISHREF=http://c.moreover.com/click/here.pl%3fz2535717020%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Preliminary study results of ExThera Medical's Seraph extracorporeal affinity therapy publishedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034526&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034526&THISHREF=http://c.moreover.com/click/here.pl%3fz2535838022%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034526&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034526&THISHREF=http://c.moreover.com/click/here.pl%3fz2535838022%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Pharmasset Reports Fiscal First Quarter 2010 Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038183&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038183&THISHREF=http://c.moreover.com/click/here.pl%3fz2537521874%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038183&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038183&THISHREF=http://c.moreover.com/click/here.pl%3fz2537521874%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Pharmasset Reports Fiscal First Quarter 2010 Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037893&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037893&THISHREF=http://c.moreover.com/click/here.pl%3fz2537362368%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037893&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037893&THISHREF=http://c.moreover.com/click/here.pl%3fz2537362368%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Pharmasset Reports Fiscal First Quarter 2010 Financial Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037810&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037810&THISHREF=http://c.moreover.com/click/here.pl%3fz2537298615%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037810&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037810&THISHREF=http://c.moreover.com/click/here.pl%3fz2537298615%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSys-Con Media: Amgen Tour Previews Posted On Webhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037574&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037574&THISHREF=http://c.moreover.com/click/here.pl%3fz2537154599%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037574&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037574&THISHREF=http://c.moreover.com/click/here.pl%3fz2537154599%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKCRA.com: ?No mountain stage ... can compare to cancer?http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036646&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036646&THISHREF=http://c.moreover.com/click/here.pl%3fz2536697456%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036646&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=End-Stage_Renal&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036646&THISHREF=http://c.moreover.com/click/here.pl%3fz2536697456%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMetro.us: